/term/inst-ownership/SHSE:603439 Guizhounli Pharmaceutical Co (SHSE:603439) Institutional Ow
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guizhou Sanli Pharmaceutical Co Ltd (SHSE:603439) » Definitions » Institutional Ownership

Guizhounli Pharmaceutical Co (SHSE:603439) Institutional Ownership : 7.75% (As of Jun. 20, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Guizhounli Pharmaceutical Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Guizhounli Pharmaceutical Co's institutional ownership is 7.75%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Guizhounli Pharmaceutical Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Guizhounli Pharmaceutical Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Guizhounli Pharmaceutical Co Institutional Ownership Historical Data

The historical data trend for Guizhounli Pharmaceutical Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhounli Pharmaceutical Co Institutional Ownership Chart

Guizhounli Pharmaceutical Co Historical Data

The historical data trend for Guizhounli Pharmaceutical Co can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 5.50 5.50 5.50 5.50 5.50 7.74 7.74 7.74 7.75 7.75

Guizhounli Pharmaceutical Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Guizhounli Pharmaceutical Co (SHSE:603439) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guizhou Sanli Pharmaceutical Co Ltd (SHSE:603439) » Definitions » Institutional Ownership
Comparable Companies
SZSE:300181 SZSE:301080 SHSE:603718 SHSE:603896 SHSE:688658 SZSE:301333 SHSE:603566 SHSE:688046 SHSE:600200 SHSE:688319 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Xiayun Industrial Park, Pingba District, Guizhou Province, Anshun, CHN, 561000
Website
http://www.gz-sanli.com
Guizhou Sanli Pharmaceutical Co Ltd is engaged in Chinese pharmaceutical research, development, production and marketing. The company produces and sells soft capsules, hard capsules, sprays (including Chinese medicine extraction) and provides Chinese medicine science and technology consulting services. Its products include Pediatric medication; Respiratory system medication; Cardiovascular and cerebrovascular drugs; Digestive medicine; Trauma injury medication; Rehabilitation medicine; and Ophthalmic medicine.
Executives
Zhang Hong Yu Directors, senior managers
Wang Yi senior management
Zhang Qian Fan Directors, senior managers
Sheng Yong Jian Director

Guizhounli Pharmaceutical Co (SHSE:603439) Headlines

No Headlines